Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T22:18:36.954Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:18:36.954Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 415,982,736
TTM revenue · period ending 2026-06-30: 0

FMP input reference: eb6c183c54b52a3f5be7b88cd35f52a8db6123751fb387d2cb2c86d403628cdc

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

RZLT PS Ratio Metrics

PS RATIO

N/A

PS RATIO AVG TTM

N/A

PS RATIO AVG 3Y

N/A

PS RATIO AVG 5Y

N/A

PS RATIO AVG 10Y

N/A

PS RATIO AVG 15Y

N/A

PS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

RZLT Competitors' PS Ratio

RZLT

Rezolute, Inc.

Current

Market Cap

$415.98M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SENS

Senseonics Holdings, Inc.

vs RZLT

Market Cap

$416.27M

PS Ratio

8.57

TTM Avg

8.95

3Y Avg

12.76

5Y Avg

30.61

EDIT

Editas Medicine, Inc.

vs RZLT

Market Cap

$418.95M

PS Ratio

8.91

TTM Avg

6.16

3Y Avg

8.52

5Y Avg

20.03

PRTA

Prothena Corporation plc

vs RZLT

Market Cap

$419.87M

PS Ratio

7.70

TTM Avg

32.56

3Y Avg

19.45

5Y Avg

53.61

MPLT

MapLight Therapeutics, Inc.

vs RZLT

Market Cap

$411.21M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTA

Strata Critical Medical, Inc.

vs RZLT

Market Cap

$411.00M

PS Ratio

1.61

TTM Avg

1.77

3Y Avg

1.36

5Y Avg

3.01

TLRY

Tilray Brands, Inc.

vs RZLT

Market Cap

$422.72M

PS Ratio

0.37

TTM Avg

0.69

3Y Avg

0.87

5Y Avg

1.45

TECX

Tectonic Therapeutic, Inc.

vs RZLT

Market Cap

$422.86M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEO

NeoGenomics, Inc.

vs RZLT

Market Cap

$424.10M

PS Ratio

0.55

TTM Avg

0.42

3Y Avg

0.50

5Y Avg

0.63

EIKN

Eikon Therapeutics, Inc. Common Stock

vs RZLT

Market Cap

$406.58M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Rezolute, Inc. (RZLT)	$415.98M	N/A	N/A	N/A	N/A
Senseonics Holdings, Inc. (SENS)vs ›	$416.27M	8.57	8.95	12.76	30.61
Editas Medicine, Inc. (EDIT)vs ›	$418.95M	8.91	6.16	8.52	20.03
Prothena Corporation plc (PRTA)vs ›	$419.87M	7.70	32.56	19.45	53.61
MapLight Therapeutics, Inc. (MPLT)vs ›	$411.21M	N/A	N/A	N/A	N/A
Strata Critical Medical, Inc. (SRTA)vs ›	$411.00M	1.61	1.77	1.36	3.01
Tilray Brands, Inc. (TLRY)vs ›	$422.72M	0.37	0.69	0.87	1.45
Tectonic Therapeutic, Inc. (TECX)vs ›	$422.86M	N/A	N/A	N/A	N/A
NeoGenomics, Inc. (NEO)vs ›	$424.10M	0.55	0.42	0.50	0.63
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$406.58M	N/A	N/A	N/A	N/A

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

RZLT PS Ratio History

DATE	PS RATIO
2019-09-09	0.41
2019-09-06	0.58
2019-09-05	0.58
2019-09-04	0.58
2019-09-03	0.50
2019-08-30	0.60
2019-08-29	0.60
2019-08-28	0.52
2019-08-27	0.70
2019-08-26	0.70
2019-08-23	0.70
2019-08-22	0.70
2019-08-21	0.70
2019-08-20	0.60
2019-08-19	0.60
2019-08-16	0.57
2019-08-15	0.62
2019-08-14	0.63
2019-08-13	0.89
2019-08-12	0.73
2019-08-09	0.76
2019-08-08	0.76
2019-08-07	0.76
2019-08-06	0.79
2019-08-05	1.01
2019-08-02	1.01
2019-08-01	1.48
2019-07-31	0.67
2019-07-30	0.67
2019-07-29	1.26
2019-07-26	1.44
2019-07-25	1.56
2019-07-24	1.20
2019-07-23	1.04
2019-07-22	1.01
2019-07-19	0.95
2019-07-18	0.87
2019-07-17	0.88
2019-07-16	0.88
2019-07-15	0.66
2019-07-12	0.66
2019-07-11	0.63
2019-07-10	0.69
2019-07-09	0.69
2019-07-08	0.69
2019-07-05	0.63
2019-07-03	0.48
2019-07-02	0.62
2019-07-01	0.62
2019-06-28	0.62
2019-06-27	0.54
2019-06-26	0.48
2019-06-25	0.48
2019-06-24	0.38
2019-06-21	0.58
2019-06-20	0.58
2019-06-19	0.58
2019-06-18	0.58
2019-06-17	0.58
2019-06-14	0.58
2019-06-13	0.58
2019-06-12	0.58
2019-06-11	0.43
2019-06-10	0.43
2019-06-07	0.43
2019-06-06	0.43
2019-06-05	0.43
2019-06-04	0.44
2019-06-03	0.44
2019-05-31	0.44
2019-05-30	0.44
2019-05-29	0.44
2019-05-28	0.44
2019-05-24	0.44
2019-05-23	0.44
2019-05-22	0.49
2019-05-21	0.61
2019-05-20	0.62
2019-05-17	0.34
2019-05-16	0.63
2019-05-15	0.63
2019-05-14	0.55
2019-05-13	0.55
2019-05-10	0.57
2019-05-09	0.65
2019-05-08	0.65
2019-05-07	0.57
2019-05-06	0.57
2019-05-03	0.57
2019-05-02	0.57
2019-05-01	0.57
2019-04-30	0.57
2019-04-29	0.57
2019-04-26	0.57
2019-04-25	0.57
2019-04-24	0.59
2019-04-23	0.60
2019-04-22	0.74
2019-04-18	0.76
2019-04-17	0.79
2019-04-16	0.70
2019-04-15	0.60
2019-04-12	1.13
2019-04-11	0.77
2019-04-10	0.72
2019-04-09	0.72
2019-04-08	0.66
2019-04-05	0.66
2019-04-04	0.60
2019-04-03	0.60
2019-04-02	0.60
2019-04-01	0.60
2019-03-29	0.63
2019-03-28	0.63
2019-03-27	0.63
2019-03-26	0.63
2019-03-25	0.63
2019-03-22	0.72
2019-03-21	0.72
2019-03-20	0.72
2019-03-19	0.72
2019-03-18	0.72
2019-03-15	0.72
2019-03-14	0.72
2019-03-13	0.53
2019-03-12	0.76
2019-03-11	0.76
2019-03-08	0.77
2019-03-07	0.77
2019-03-06	0.63
2019-03-05	0.79
2019-03-04	0.92
2019-03-01	0.95
2019-02-28	0.95
2019-02-27	1.19
2019-02-26	0.95
2019-02-25	0.95
2019-02-22	0.76
2019-02-21	0.76
2019-02-20	0.76
2019-02-19	0.63
2019-02-15	0.60
2019-02-14	0.60
2019-02-13	0.64
2019-02-12	0.76
2019-02-11	0.76
2019-02-08	0.76
2019-02-07	0.76
2019-02-06	0.76
2019-02-05	0.76
2019-02-04	0.63
2019-02-01	0.76
2019-01-31	0.76
2019-01-30	0.76
2019-01-29	0.76
2019-01-28	0.76
2019-01-25	0.76
2019-01-24	0.76
2019-01-23	0.76
2019-01-22	0.76
2019-01-18	0.76
2019-01-17	0.76
2019-01-16	0.85
2019-01-15	0.85
2019-01-14	0.85
2019-01-11	0.76
2019-01-10	0.76
2019-01-09	0.85
2019-01-08	0.97
2019-01-07	1.11
2019-01-04	0.32
2019-01-03	0.28
2019-01-02	0.28

Fiscal period	Revenue	Source
Q1 FY2026Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06
Q2 FY2026Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12
Q3 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12
Q4 FY2026Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-24
TTM revenue	$0

PS Ratio: N/A

RZLT PS Ratio Chart

RZLT PS Ratio Metrics

RZLT Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

RZLT PS Ratio History

Related Metrics